Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation
Purpose: To report a case of Coats’ disease managed with the dexamethasone intravitreal implant Ozurdex® (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation. Methods: A 46-year-old female with 20/200 visual acuity was diagnosed with Coats’ disease with secondary retinal vaso...
Main Authors: | Sebastián Martínez-Castillo, Roberto Gallego-Pinazo, Rosa Dolz-Marco, Cristina Marín-Lambíes, Manuel Díaz-Llopis |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2012-03-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/337481 |
Similar Items
-
To study the effect of intravitreal ozurdex implant in cases of retinal vein occlusion
by: Shailender K Chaudhary, et al.
Published: (2022-01-01) -
Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report
by: Cansu Ekinci, et al.
Published: (2019-06-01) -
Dexamethasone Implant (Ozurdex) in a Case with Unilateral Simultaneous Central Retinal Vein and Branch Retinal Artery Occlusion
by: Taylan Ozturk, et al.
Published: (2015-02-01) -
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
by: Eun Young Choi, et al.
Published: (2019-04-01) -
Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
by: Saud M Aljohani, et al.
Published: (2021-01-01)